Ken Griffin Anika Therapeutics, Inc. Transaction History

Citadel Advisors LLC

$618 Billion
Q3 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 19,383 shares of ANIK stock, worth $192,667. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,383

Previous 28,253 31.39%

Holding current value

$192,667

Previous $298,000 38.93%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$8.1 - $11.78 $71,847 - $104,488	-8,870 Reduced 31.39%	19,383 $182,000
Q2 2025 Aug 14, 2025	SELL	$10.58 - $15.05 $425,136 - $604,754	-40,183 Reduced 58.72%	28,253 $298,000
Q1 2025 May 15, 2025	SELL	$15.03 - $17.97 $46,577 - $55,689	-3,099 Reduced 4.33%	68,436 $1.03 Million
Q4 2024 Feb 14, 2025	BUY	$16.04 - $25.53 $472,618 - $752,241	29,465 Added 70.04%	71,535 $1.18 Million
Q3 2024 Nov 14, 2024	SELL	$24.25 - $28.75 $1.14 Million - $1.35 Million	-47,063 Reduced 52.8%	42,070 $1.04 Million

Q2 2024 Aug 14, 2024	BUY	$24.57 - $28.47 $1.2 Million - $1.39 Million	48,931 Added 121.71%	89,133 $2.26 Million
Q1 2024 May 15, 2024	SELL	$21.95 - $26.42 $3.28 Million - $3.94 Million	-149,248 Reduced 78.78%	40,202 $1.02 Million
Q4 2023 Feb 14, 2024	BUY	$18.47 - $23.3 $1.14 Million - $1.44 Million	61,781 Added 48.39%	189,450 $4.29 Million
Q3 2023 Nov 14, 2023	BUY	$16.98 - $26.1 $1.78 Million - $2.74 Million	104,975 Added 462.57%	127,669 $2.38 Million
Q2 2023 Aug 14, 2023	BUY	$25.16 - $28.86 $382,054 - $438,239	15,185 Added 202.22%	22,694 $589,000
Q1 2023 May 15, 2023	SELL	$25.91 - $32.1 $1.87 Million - $2.32 Million	-72,254 Reduced 90.59%	7,509 $215,000
Q4 2022 Feb 14, 2023	BUY	$23.85 - $31.91 $1.56 Million - $2.08 Million	65,256 Added 449.82%	79,763 $2.36 Million
Q3 2022 Nov 14, 2022	BUY	$21.74 - $24.68 $315,382 - $358,032	14,507 New	14,507 $345,000
Q3 2021 Nov 15, 2021	SELL	$38.75 - $44.47 $786,586 - $902,696	-20,299 Reduced 40.37%	29,985 $1.28 Million
Q2 2021 Aug 16, 2021	BUY	$39.42 - $48.08 $1.19 Million - $1.46 Million	30,300 Added 151.62%	50,284 $2.18 Million
Q1 2021 May 17, 2021	SELL	$32.49 - $45.96 $77,976 - $110,304	-2,400 Reduced 10.72%	19,984 $815,000
Q4 2020 Feb 16, 2021	SELL	$32.59 - $45.26 $970,562 - $1.35 Million	-29,781 Reduced 57.09%	22,384 $1.01 Million
Q3 2020 Nov 16, 2020	BUY	$32.56 - $38.57 $575,823 - $682,110	17,685 Added 51.29%	52,165 $1.85 Million
Q2 2020 Aug 14, 2020	SELL	$27.83 - $37.73 $1.57 Million - $2.12 Million	-56,282 Reduced 62.01%	34,480 $1.3 Million
Q1 2020 May 15, 2020	SELL	$22.38 - $54.06 $511,964 - $1.24 Million	-22,876 Reduced 20.13%	90,762 $2.62 Million
Q4 2019 Feb 14, 2020	SELL	$51.85 - $73.36 $772,202 - $1.09 Million	-14,893 Reduced 11.59%	113,638 $5.89 Million
Q3 2019 Nov 14, 2019	BUY	$40.05 - $57.47 $735,077 - $1.05 Million	18,354 Added 16.66%	128,531 $7.06 Million
Q2 2019 Aug 14, 2019	SELL	$30.3 - $41.14 $1.52 Million - $2.06 Million	-50,082 Reduced 31.25%	110,177 $4.48 Million
Q1 2019 May 15, 2019	BUY	$29.37 - $40.49 $2.03 Million - $2.8 Million	69,050 Added 75.71%	160,259 $0
Q4 2018 Feb 14, 2019	SELL	$30.16 - $43.0 $99,135 - $141,341	-3,287 Reduced 3.48%	91,209 $3.07 Million
Q3 2018 Nov 13, 2018	SELL	$32.83 - $42.51 $2.1 Million - $2.72 Million	-64,013 Reduced 40.38%	94,496 $0
Q2 2018 Aug 10, 2018	BUY	$28.77 - $48.27 $3.21 Million - $5.39 Million	111,664 Added 238.37%	158,509 $0
Q1 2018 May 11, 2018	BUY	$49.22 - $68.43 $589,950 - $820,201	11,986 Added 34.38%	46,845 $2.33 Million
Q4 2017 Feb 09, 2018	BUY	$52.14 - $59.94 $550,077 - $632,367	10,550 Added 43.4%	34,859 $1.88 Million
Q3 2017 Nov 09, 2017	BUY	$51.16 - $58.21 $1.24 Million - $1.42 Million	24,309	24,309 $1.41 Million

Others Institutions Holding ANIK

# of Institutions

118

Shares Held

10.7M

Call Options Held

Put Options Held

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $145M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account